As expected, subjective and composite remission rates defined by patient VAS ≤ 1 cm, HAQ-DI < 0.5, SDAI ≤ 3.3, and Boolean-based remission were greater in patients with RA with negative joint counts and normal CRP values than the remaining patients with RA (71.8% vs 29.2%, p < 0.0001; 78.5% vs 45.8%, p < 0.0001; 83.9% vs 16.8%, p < 0.0001; and 71.8% vs 16.1%, p < 0.0001; respectively). This evidence concerns the gene CRP and rheumatoid arthritis.